FDA Inspection 1081743 — Kelly K. Nichols, O.D., Ph.D.
The FDA completed an inspection of Kelly K. Nichols, O.D., Ph.D. on Feb 27, 2019 in Birmingham, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 27, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Birmingham, AL (United States)
Additional Details
Clinical Investigator (CI)